|
|
About Us
Eastland is a publicly listed Company on the Australian Securities Exchange (ASX:EMS) that is involved in the commercialisation of low risk pharmaceutical projects.
The Company’s key project is ArTiMist™, a malaria treatment developed specifically for children with severe malaria.
ArTiMist has the potential to save countless young lives throughout third world and underprivileged regions.
|
|
|
Growth Strategy
Eastland is committed to developing its pharmaceutical business model by expanding its product portfolio with products that demonstrate major cost, functional and effectual advantages over competitors, thereby securing on-going consumer demand.
|
|
